Hope for Veterans: Updates in the Management and Treatment of BCC, cSCC, Melanoma, Multiple Myeloma, NHL and NSCLC

Welcome to the AVAHO immuno-oncology resource website. Here you can view numerous animations on cutaneous malignancies, hematologic cancers, and non-small cell lung cancer, including programs on their pathophysiology, interactions with the immune system, and the mechanism of action of the latest immunotherapies in these diseases.

This activity is provided by Med Learning Group.
This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM).
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2024 Med Learning Group. Built by Divigner. All Rights Reserved.

Encompass HD Visual Learning

Non-small Cell Lung Cancer:
Today, lung cancer is the leading cause of cancer death in the United States, making up over a quarter of all cancer-related deaths. For veterans of the US military and other industries, the risk of being diagnosed with the disease is even higher.

US Department of Veterans Affairs (VA). VA and GO2 Foundation for Lung Cancer partner to improve outcomes for veterans at risk of lung cancer. https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5468

Lung Cancer Center. Lung Cancer in the Military.
https://www.lungcancercenter.com/who-lung-cancer-affects/military/

Click on the button below for more resources and tools that aims to provide clinicians up-to-date information on Encompass

NSCLC HD Visual Learning

Non-small Cell Lung Cancer:
Today, lung cancer is the leading cause of cancer death in the United States, making up over a quarter of all cancer-related deaths. For veterans of the US military and other industries, the risk of being diagnosed with the disease is even higher.

US Department of Veterans Affairs (VA). VA and GO2 Foundation for Lung Cancer partner to improve outcomes for veterans at risk of lung cancer. https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5468

Lung Cancer Center. Lung Cancer in the Military.
https://www.lungcancercenter.com/who-lung-cancer-affects/military/

Click on the button below for more resources and tools that aims to provide clinicians up-to-date information on Non-small Cell Lung Cancer (NSCLC)

NHL HD Visual Learning

Non-Hodgkin’s Lymphoma:
In 2023, more than 80,000 NHLs will be diagnosed, and more than 20,000 patients will succumb to various forms of this heterogeneous group of cancers. The Selected Cancers Cooperative Study Group reported an increased risk of NHL among Vietnam veterans compared with men who did not serve in Vietnam, with increased risk relative to the length of service.

American Cancer Society. Cancer Facts & Figures 2023. Atlanta: American Cancer Society; 2023.
Dalager NA, et al. J Occup Med. 1991;33:774-779.

American Cancer Society. Cancer Facts & Figures 2023. Atlanta: American Cancer Society; 2023.
The association of selected cancers with service in the US military in Vietnam: I. Non-Hodgkin’s lymphoma. Arch Intern Med. 1990;150:2473-2483.

Click on the button below for more resources and tools that aims to provide clinicians up-to-date information on Non-Hodgkin’s Lymphoma (NHL)

Multiple Myeloma HD Visual Learning

Multiple Myeloma:
Multiple myeloma, although a rare disease, is the second most common hematologic malignancy. The aging veteran population represents a distinct demographic with potential exposures to various carcinogens linked to the development of multiple myeloma including Agent Orange, burn pits, radiation, and contaminated water.

Kazandjian D. Semin Oncol. 2016;43:676-681. Mahmood S, et al. J Clin Oncol. 2023;41(16_suppl):e20061.

American Cancer Society. Cancer Facts & Figures 2023. Atlanta: American Cancer Society; 2023.
Chang MS, et al. J Am Acad Dermatol. 2022;87:72-79.

Click on the button below for more resources and tools that aims to provide clinicians up-to-date information on Multiple Myeloma

Melanoma HD Visual Learning

Cutaneous Cancers:
Veteran and US active-duty populations have an increased risk of developing melanoma and non-melanoma skin cancers than the general population. An Air Force study of 356 maintenance squadrons found that 67% of those surveyed received direct sun exposure while on the job and, while most of those interviewed knew that sunscreen could prevent skin cancer, less than 11% used it most of the time.

Riemenschneider K, et al. J Am Acad Dermatol. 2018;78:1185-1192.

American Cancer Society. Cancer Facts & Figures 2023. Atlanta: American Cancer Society; 2023.
Chang MS, et al. J Am Acad Dermatol. 2022;87:72-79.

Click on the button below for more resources and tools that aims to provide clinicians up-to-date information on Melanoma

cSCC HD Visual Learning

Cutaneous Cancers:
Veteran and US active-duty populations have an increased risk of developing melanoma and non-melanoma skin cancers than the general population. An Air Force study of 356 maintenance squadrons found that 67% of those surveyed received direct sun exposure while on the job and, while most of those interviewed knew that sunscreen could prevent skin cancer, less than 11% used it most of the time.

Riemenschneider K, et al. J Am Acad Dermatol. 2018;78:1185-1192.

Sung H, et al. CA Cancer J Clin. 2021:71:209-249. Olsen CM, et al. Aust N Z J Public Health. 2015;39:471-476.
Karia PS, et al. J Am Acad Dermatol. 2013;68:957-966. Weinberg AS, et al. Dermatol Surg. 2007;33:885-899.
Kim JYS, et al. J Am Acad Dermatol. 2018;78:560-578.
Eigentler TK, et al. J Invest Dermatol. 2017;137:2309-2315

Click on the button below for more resources and tools that aims to provide clinicians up-to-date information on Cutaneous Squamous Cell Carcinoma (cSCC)

BCC HD Visual Learning

Cutaneous Cancers:
Veteran and US active-duty populations have an increased risk of developing melanoma and non-melanoma skin cancers than the general population. An Air Force study of 356 maintenance squadrons found that 67% of those surveyed received direct sun exposure while on the job and, while most of those interviewed knew that sunscreen could prevent skin cancer, less than 11% used it most of the time.

Riemenschneider K, et al. J Am Acad Dermatol. 2018;78:1185-1192.

Riemenschneider K, et al. J Am Acad Dermatol. 2018;78:1185-1192. Sung H, et al. CA Cancer J Clin. 2021:71:209-249.
Verkouteren JAC, et al. Br J Dermatol. 2017;177:359-372. Olsen CM, et al. Aust N Z J Public Health. 2015;39:471-476.
Kushnir-Grinbaum D, et al. Acta Derm Venereol. 2023;103:adv00841.

Click on the button below for more resources and tools that aims to provide clinicians up-to-date information on Basal Cell Carcinoma (BCC)